2020 Outlook and Opportunities

Here’s a prediction: Healthcare M&A will remain strong in 2020, at least until the November presidential election. Unless a recession hits before then. All of the analysts, lawyers and investment bankers we’ve spoken to in recent months agree on that scenario. Everyone is seeing robust deal flow and/or pipelines but knows the uncertainties that are sure to play out through the Democratic presidential primaries and into the general election could adversely affect this market. Their predictions are based on what has become status quo in the financial world. Low inflation, low cost of capital and a lot of money sitting in private funds on the sidelines, just waiting to get into the game.... Read More »
New Buyers Move in to Home Health & Hospice

New Buyers Move in to Home Health & Hospice

The Home Health & Hospice sector is poised for big deals in 2018. As the healthcare industry shifts inexorably toward value-based reimbursement models, this sector has become the “go-to” care protocol to help drive down costs and to keep patients out of institutions. However, the pressures that existed in 2017 are still present in 2018, and even amplified now. Mark Kulik, managing director at The Braff Group, recently gave us his view of the market. Not only will the rate of M&A activity accelerate, new buyers will enter the market. “Ten years ago, people stayed in their lane. Today, we’re going out to a wider range of buyers, such as long-term care and... Read More »